- £671.31m
- £907.41m
- £608.30m
- 76
- 39
- 13
- 35
Annual income statement for CVS, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 407 | 428 | 510 | 554 | 608 |
| Cost of Revenue | |||||
| Gross Profit | 169 | 170 | 222 | 239 | 262 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 391 | 409 | 470 | 511 | 546 |
| Operating Profit | 15.6 | 18.5 | 40.1 | 42.8 | 62.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 11.7 | 9.9 | 33.1 | 36 | 53.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 8.2 | 5.7 | 19.3 | 25.7 | 41.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 8.2 | 5.7 | 19.3 | 25.7 | 41.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 8.2 | 5.7 | 19.3 | 25.7 | 41.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.119 | 0.125 | 0.273 | 0.48 | 0.655 |
| Dividends per Share |